Vascular actions of insulin with implications for endothelial dysfunction
Maria Assunta Potenza1, Francesco Addabbo, Monica Montagnani
1Department of Pharmacology and Human Physiology, Medical School, University of Bari, Bari, Italy.
Summary
Insulin regulates vascular function by stimulating endothelial mediators like nitric oxide (NO) and endothelin-1 (ET-1). Insulin resistance disrupts this balance, contributing to endothelial dysfunction and vascular disease.
Area of Science:
- Vascular Biology
- Endocrinology
- Cardiovascular Physiology
Background:
- Insulin's hemodynamic effects rely on endothelial mediators.
- Nitric oxide (NO), endothelin-1 (ET-1), and reactive oxygen species (ROS) are key mediators with opposing vascular actions.
- Endothelial dysfunction, marked by reduced NO bioavailability, is linked to vascular complications.
Purpose of the Study:
- To review signaling pathways in insulin-stimulated release of NO, ET-1, and ROS.
- To explore mechanisms linking abnormal insulin signaling to endothelial dysfunction.
Main Methods:
- Review of existing literature on insulin signaling and endothelial mediators.
- Analysis of intracellular pathways regulating mediator release.
- Discussion of molecular mechanisms in insulin resistance.
Main Results:
- Insulin activates distinct pathways for NO, ET-1, and ROS release.
- Impaired insulin signaling in insulin resistance can disrupt mediator balance.
- This imbalance contributes to the pathogenesis of vascular abnormalities.
Conclusions:
- Understanding insulin's role in mediator release is crucial for addressing endothelial dysfunction.
- Abnormal insulin signaling pathways are implicated in vascular complications associated with metabolic disorders.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...